Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bastide Le Confort MedicalLTS:0IP1 71 Cyclically Adjusted PB Ratio is 2.17 as of Jul. 18, 2026, which is 50% below its 10-year median of 4.34. GuruFocus rates LTS:0IP1 with a GF Score™ of 71/100 and a GF Value™ of €25.93 (Fairly Valued). The stock has 2 warning signs investors should review. Among 92 Medical Distribution companies, Bastide Le Confort Medical ranks worse than 72.83% on this metric.
The historical rank and industry rank for Bastide Le Confort Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:
LTS:0IP1'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.35 Med: 4.34 Max: 9.3
Current: 2.12
During the past 13 years, Bastide Le Confort Medical's highest Cyclically Adjusted PB Ratio was 9.30. The lowest was 1.35. And the median was 4.34.
LTS:0IP1's Cyclically Adjusted PB Ratio is ranked worse than 72.83% of 92
companies
in the Medical Distribution industry
Industry Median: 1.19
vs LTS:0IP1: 2.12
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Bastide Le Confort Medical's adjusted book value per share data of for the fiscal year that ended in Jun25 was €9.868. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €10.97 for the trailing ten years ended in Jun25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Bastide Le Confort Medical (LTS:0IP1) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Bastide Le Confort Medical Cyclically Adjusted PB Ratio Related Terms
Bastide Le Confort Medical Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for Bastide Le Confort Medical's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical Cyclically Adjusted PB Ratio Chart
LTS:0IP1 vs MCK, CAH, COR: Cyclically Adjusted PB Ratio Comparison
For the Medical Distribution subindustry, Bastide Le Confort Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical Cyclically Adjusted PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's Cyclically Adjusted PB Ratio falls into.
Bastide Le Confort Medical Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 2.17 mean?
Bastide Le Confort Medical (LTS:0IP1) has a Cyclically Adjusted PB Ratio of 2.17 as of Jul. 18, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Bastide Le Confort Medical and its competitors. This is 50% below median its historical median of 4.34. Over the past decade, Bastide Le Confort Medical's Cyclically Adjusted PB Ratio has ranged from 1.35 to 9.30. According to the industry distribution chart, Bastide Le Confort Medical ranks #67 out of 92 companies in the Medical Distribution industry, placing it in the top 72.8%.
Is Bastide Le Confort Medical's Cyclically Adjusted PB Ratio too high?
Bastide Le Confort Medical's current Cyclically Adjusted PB Ratio of 2.17 is 50% below median its 10-year median of 4.34. Over the past 10 years, this metric has ranged from a low of 1.35 to a high of 9.30. The Medical Distribution industry median Cyclically Adjusted PB Ratio is 1.19. Bastide Le Confort Medical's value of 2.17 is 82.4% above this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #67 out of 92 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's Cyclically Adjusted PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #67 out of 92 companies for Cyclically Adjusted PB Ratio. This places Bastide Le Confort Medical in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.19. Bastide Le Confort Medical's value of 2.17 is 82.4% above this benchmark. Historically, Bastide Le Confort Medical's own Cyclically Adjusted PB Ratio has ranged from 1.35 to 9.30 over the past decade. While the company's 10-year median is 4.34 vs. the industry median of 1.19, Bastide Le Confort Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Distribution company?
The median Cyclically Adjusted PB Ratio among Medical Distribution companies is 1.19, based on 92 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current Cyclically Adjusted PB Ratio of 2.17 is 82.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median Cyclically Adjusted PB Ratio is 1.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current Cyclically Adjusted PB Ratio is 2.17, which is 50% below median its own 10-year median of 4.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Fairly Valued. The stock's GF Value™ is €25.93, compared to a current price of €23.80 — trading 8.2% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 2.17, which is 50% below median its 10-year median of 4.34 and 82.4% above the Medical Distribution industry median of 1.19. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current Cyclically Adjusted PB Ratio is 2.17 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €23.80 is trading 8.2% below its estimated GF Value™ of €25.93.
GuruFocus considers Bastide Le Confort Medical to be Fairly Valued.
Key valuation signals for LTS:0IP1:
Cyclically Adjusted PB Ratio: 2.17 (50% below median its 10-year median of 4.34)
GF Value™: €25.93 vs. price of €23.80 (8.2% below fair value)
Industry Position: 82.4% above the Medical Distribution median (#67 of 92)
No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score
Get the complete analysis for LTS:0IP1
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0IP1 has been successfully added to your 
